The effect of 3,7-diazabicyclo[3.3.1]nonanes containing monoterpenoid moieties on the physical activity of mice

The aim of this work is to study the effect of agents combining fragments of monoterpenoids and 3,7-diazabicyclo[3.3.1]nonane (bispidine) on the performance of mice. Physical endurance was studied using two tests: exhaustive swimming with a load of 7% of body weight (after single dosing) and exhaust...

Full description

Saved in:
Bibliographic Details
Published inJournal of Research in Pharmacy Vol. 24; no. 2; p. 196
Main Authors KOTLYAROVA, Anastasiya A, Konstantin Yu. PONOMAREV, MOROZOVA, Ekaterina A, KORCHAGINA, Dina V, SUSLOV, Evgeniy V, PAVLOVA, Alla V, TOLSTIKOVA, Tatyana G, VOLCHO, Konstantin P, SALAKHUTDINOV, Nariman F
Format Journal Article
LanguageEnglish
Published Istanbul Marmara University 01.01.2020
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this work is to study the effect of agents combining fragments of monoterpenoids and 3,7-diazabicyclo[3.3.1]nonane (bispidine) on the performance of mice. Physical endurance was studied using two tests: exhaustive swimming with a load of 7% of body weight (after single dosing) and exhaustive treadmill running (after single dosing and a 7-day administration). It has been shown for the first time that derivatives of monoterpenoids with 3,7-diazabicyclo[3.3.1]nonane moiety containing methyl substituents at positions 1 and 5 have a stimulatory effect on the performance of mice, which exceeds the effect of the reference drug bromantane after single dosing. Compound K1-458, which contains (–)-myrtenal residues linked to a bispidine fragment via amino groups, is the most effective in increasing the duration of running and swimming at a dose of 100 mg/kg after single intragastric administration. It has been also established that the LD50 for these compounds exceeds 1,000 mg/kg.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:2630-6344
2630-6344
DOI:10.35333/jrp.2020.136